Principal Investigator
Michael Fabbro
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220234
Clinical Trial Summary
Optimal Protamine Dosing For Heparin Reversal Following Cardiopulmonary Bypass: A Blinded Randomized Control Trial Comparing Two Strategies
Phase
N/A
Funding Agency/Sponsor
Intramural
Disease
Other